Neumora Therapeutics Inc (NMRA) 1.63 USD (-0.07%)

Neumora Therapeutics Inc develops advanced treatments for neurological diseases using data-driven discovery and development platforms.

biotechnology medical-research

Price history of Neumora Therapeutics Inc

Performance & Momentum

6 Months 25.57 %

1 Year 59.80 %

3 Years 90.41 %

5 Years 89.97 %

Momentum

Unlock this indicator

Strategic Analysis

Neumora Therapeutics Inc • 2026

Neumora Therapeutics positions itself as an innovative player in biotechnology by targeting neurological diseases through a data-integration-based approach designed to accelerate the discovery and development of treatments. Its data-driven specialization provides notable differentiation in a highly competitive sector with significant medical stakes.

Strengths

Advanced technological approach combining biotechnology and data analysis to optimize R&D
Focus on neurological diseases, an area where medical needs remain broad and unmet
High growth potential linked to recent breakthroughs, reflected in strong recent share-price momentum

Weaknesses

Stock market history marked by high volatility and significant negative performance over the long term
Lack of recent major news, which may sustain uncertainty around pipeline development

Momentum

Short- and medium-term momentum is very favorable, reflecting renewed investor interest likely linked to clinical progress or partnerships. This positive trend supports a cautious but opportunistic exposure strategy, in the context of high risk associated with its volatile past.

Analysis performed 1 month ago